Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ AGPAT9 Monoclonal Antibody (OTI3H3)

Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA527210
Description
AGPAT9 Monoclonal Antibody for Western Blot
This gene encodes a member of the lysophosphatidic acid acyltransferase protein family. The encoded protein is an enzyme which catalyzes the conversion of glycerol-3-phosphate to lysophosphatidic acid in the synthesis of triacylglycerol. Multiple alternatively spliced variants, encoding the same protein, have been identified.
Specifications
| AGPAT9 | |
| Monoclonal | |
| 1 mg/mL | |
| PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3 | |
| Q53EU6 | |
| GPAT3 | |
| Human recombinant protein fragment corresponding to amino acids 41-131 of AGPAT9 produced in E.coli. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG1 |
| Western Blot | |
| OTI3H3 | |
| Unconjugated | |
| GPAT3 | |
| 1-acylglycerol-3-phosphate O-acyltransferase 8; 1-acylglycerol-3-phosphate O-acyltransferase 9; 1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10; 1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9; 1-AGP acyltransferase 9; 1-AGPAT; 1-AGPAT 9; 4933407I02Rik; 4933408F15; 9; A230097K15Rik; acyl-CoA:glycerol-3-phosphate acyltransferase 3; AGPAT 10; AGPAT10; AGPAT8; AGPAT9; endoplasmic reticulum associated GPAT; glycerol-3-phosphate acyltransferase 3; GPAT3; GPAT-3; hGPAT3; HMFN0839; LPAAT-theta; lung cancer metastasis-associated protein 1; Lysophosphatidic acid acyltransferase theta; lysophosphatidic acid acyltransferase, theta; MAG1; MAG-1; mGPAT3; testis secretory sperm-binding protein Li 213e; UNQ2753/PRO6492 | |
| Mouse | |
| Affinity Chromatography | |
| RUO | |
| 84803 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction